International

Protests, waning patience test U.S. restrictions

Darpan News Desk The Canadian Press, 09 Feb, 2022 10:58 AM

WASHINGTON - Safety measures aimed at curbing the spread of COVID-19 seem to gradually be giving way in parts of the United States.

Massachusetts and New York are the latest Democrat-led states to ease mask mandates, despite evidence that the surge in the Omicron variant is not yet over.

They follow similar announcements this week in New Jersey, California, Connecticut, Delaware and Oregon.

Public health officials, however, remain divided over whether the time has come to begin easing restrictions.

The Centers for Disease Control and Prevention continue to recommend wearing a mask in indoor settings where the risk of transmission is high.

CDC director Dr. Rochelle Walensky says the agency will continue to review and update its guidance based on the latest available science and data.

Prev Next

MORE International ARTICLES

Trump formally lets Canadian aluminum off hook

The U.S. president formally signed a proclamation today exempting Canadian aluminum exports from punitive Section 232 tariffs.

Trump formally lets Canadian aluminum off hook

Prince Harry says ignorance no excuse for unconscious bias

Harry talked about racial inequality and social justice in a video discussion with the Black Lives Matter activist Patrick Hutchinson as part of the GQ Heroes Conference, which is being broadcast this week.

Prince Harry says ignorance no excuse for unconscious bias

Halloween goes on at the White House with a few twists

In years past, the president and first lady personally handed out candy to the costume-clad kids. This year, the treats were provided separately as participants walked along a path on the South Lawn.

Halloween goes on at the White House with a few twists

AstraZeneca resuming US testing of COVID-19 vaccine

The AstraZenca vaccine, developed with Oxford University, is one of several coronavirus vaccine candidates in final-stage testing around the world.

AstraZeneca resuming US testing of COVID-19 vaccine

FDA approves first COVID-19 drug: antiviral remdesivir

The drug, which California-based Gilead Sciences Inc. is calling Veklury, cut the time to recovery by five days — from 15 days to 10 on average — in a large study led by the U.S. National Institutes of Health.